Detection of glyco‐mucin profiles improves specificity of MUC16 and MUC1 biomarkers in ovarian serous tumours

The CA125 assay detects circulating MUC16 and is one of the most widely used cancer biomarkers for the follow‐up of ovarian cancer. We previously demonstrated that detection of aberrant cancer‐associated glycoforms of MUC16 as well as MUC1 in circulation could improve the yield of these serum assays...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Oncol
Autors principals: Ricardo, Sara, Marcos-Silva, Lara, Pereira, Daniela, Pinto, Rita, Almeida, Raquel, Söderberg, Ola, Mandel, Ulla, Clausen, Henrik, Felix, Ana, Lunet, Nuno, David, Leonor
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2014
Matèries:
Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5528651/
https://ncbi.nlm.nih.gov/pubmed/25454345
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2014.10.005
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars